• PDF: Delivered by email within 12 to 24 hours of placing the order (Mon-Fri

2008 U.S. Inflammatory Diseases Drug Delivery
Physician Perspective

  • Publication Date:November 2010
  • Publisher:Frost & Sullivan
  • Product Type: Report
  • Pages:45

2008 U.S. Inflammatory Diseases Drug Delivery Physician Perspective

This study encompasses feedback provided by U.S. physicians who treat inflammatory diseases on aspects of drug delivery and drug treatment, enabling interested stakeholders to gain insight into current and future trends. Analysis includes issues such as awareness, usage, preferences, influencing criteria, patient compliance, desired delivery types to be made available, as well as feedback on the role the device plays in the prescribing decision for a drug. The corresponding patient deliverable is titled: "2008 U.S. Inflammatory Diseases Drug Delivery: Patient Perspective" (N835).

This Frost & Sullivan research service titled 2008 U.S. Inflammatory Diseases Drug Delivery: Physician Perspective provides the views of 89 physicians, who treat inflammatory diseases, on aspects of drug delivery for inflammatory diseases consisting of rheumatoid arthritis, Crohn’s disease, and psoriasis. This feedback offers interested stakeholders insights into current and future trends. It details their views on patient compliance with medication instructions, factors impacting prescriptions for inflammatory diseases, and preferences for inflammatory diseases medications. Respondents were asked about general awareness of drug delivery types, availability and usage, frequency of usage, satisfaction and reason for satisfaction with method used, willingness and reasons for willingness to use, barriers for usage, and reasons for preferences.

This study aims to distinguish drug delivery trends in the inflammatory diseases drug delivery market, determine product attributes relative to delivery that are considered important, identify prospective doctors’ preferences and willingness to try new technologies, and determine key drivers of adoption/non-adoption. In this research, Frost & Sullivan's expert analysts thoroughly examine the following types of drug delivery: autoinjectors, transdermal patch, oral drug delivery, intranasal, pulmonary, implant, and ocular.

Market Overview

Oral Medications and Injections Trump Other Delivery Types in the U.S. Inflammatory Disease Drug Delivery Market

According to doctors, oral medications and injections are the most frequently prescribed or administered types of drugs for the treatment of inflammatory diseases. Doctors were most satisfied with oral medications, followed by injection and intravenous infusion. Almost 15 percent of prescribers are very dissatisfied or dissatisfied with transdermal patchers and topic gels/creams. Patients’ ease of use and convenience are the key reasons for preferring oral drugs to most other forms of delivery, while perceived patient satisfaction is the top reason for preferring injections. “Doctors most commonly prescribe or administer corticosteroids, vitamin D analogues, and combination products for psoriasis, while disease modifying antirheumatic drugs (DMARDs) are preferred for rheumatoid arthritis,” says the analyst of this research. “For Crohn’s disease, corticosteroids and aminosalicytates are the most prescribed or administered.”

The majority of respondents are willing to prescribe new drug delivery forms. Of these, 46 percent believe that they adopt new drug delivery forms earlier than their peers. In all, 75 percent of patients that use oral drug delivery for their psoriasis treatment are very satisfied/satisfied against only 55 percent of topical gel/cream users being satisfied/very satisfied. “Reasons for satisfaction with the oral drug delivery method are its ease of self administration (60 percent of patients), low cost (20 percent of patients), and convenience (20 percent of patients),” notes the analyst. “Sixty six percent of Crohn’s disease patients and 91 percent of rheumatoid arthritis patients noted they are very satisfied/satisfied with oral delivery use in their treatment.”

Market Sectors

Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this research:

By Type of Inflammatory Diseases:

  • Rheumatoid arthritis
  • Psoriasis
  • Crohn’s disease medications and drug delivery


By Type of Drug Delivery:

  • Autoinjectors
  • Transdermal patch
  • Oral drug delivery
  • Intranasal
  • Pulmonary
  • Implant
  • Ocular

1. Research Background, Objectives, Method Details and Demographic Profile

2. Executive Summary

3. Overview of Awareness, Usage and Preferences

4. General Criteria and Perceptions that Influence Drug Delivery Type Preference

5. Profile of Patient Compliance and Administering Persons

6. About Frost & Sullivan

List of Figures
Demographic Profile: Doctors - Area of Specialization
Demographic Profile: Doctors - Diseases Treated
Inflammatory Disease Delivery Methods - Awareness and Preferences
Perceived Association of Delivery Types with Various Attributes
Awareness of Drug Delivery Type
Share of Prescription/Usage
Frequency of Usage of Drug Delivery Method
Satisfaction with Inflammatory Diseases Drug Delivery Method
Preferred Delivery Method
Reason for Preference of Drug Delivery Methods
Perceived Unavailable but Desirable Drug Delivery Method
Reasons for Drug Delivery Method to be Made Available
Doctors' Perception of Patients' Preferences
Perceived Reasons for Patients' Preference
Class of Drug Prescribed by Physician - Treatment Focus
Drug Delivery Method Preferred for Class of Drug
Drug Delivery Method - Trends for Next 12-24 Months
Top 5 Factors for Selecting Drug Delivery Type
Perceived Association of Delivery Types with Various Attributes
Attitude Towards New Delivery Forms
Importance of Overall Device in Final Selection to Prescribe
Device Driven Drug Delivery - Top 5 Factors that Influence Selection
Patient's Adherence to Therapy by Drug Delivery Method
Factors Affecting Patient Compliance
Person Who Administers the Medication

+44 20 8816 8548

Ask a question about 2008 U.S. Inflammatory Diseases Drug Delivery

Enter the characters you see in the picture below
Captcha